Anuh Pharma has introduced an advantage factor within the ratio of one: 1, which has an X-date in the present day. The corporate’s stocks rose 0.89 in line with cent to near at Rs 207.75 an afternoon prior to. This company motion has stuck consideration to inventory, which has a marketplace capitalization of Rs 520.56 crore.
1: 1 bonus factor implies that in keeping with the stocks that shareholders have these days, they’re going to be given a stocks on each and every inventory unfastened. X-det, this is, if any individual purchased the inventory after that date, he’ll now not get an advantage proportion. The X date of Anuh Pharma in the present day is July 15, 2025. This date is necessary for traders who wish to be entitled to bonuses.
Investigating the monetary efficiency of Anuh Pharma, the corporate recorded a gross sales of Rs 661 crore for the tip of March 2025, in comparison to Rs 647 crore within the earlier yr. The opposite source of revenue was once Rs 9 crore, inflicting the overall source of revenue to Rs 670 crore. The whole expenditure for a similar length was once Rs 609 crore, leading to an Ebit of Rs 61 crore. The online benefit for the yr ended March 2025 was once Rs 47 crore.
| Metric | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Gross sales | 661 | 647 | 527 | 486 | 431 |
| Different source of revenue | 9 | 12 | 6 | 5 | 10 |
| Overall source of revenue | 670 | 659 | 533 | 491 | 442 |
| Overall expenditure | 609 | 580 | 485 | 451 | 402 |
| EBIT | 61 | 78 | 47 | 40 | 40 |
| Hobby | 0 | 0 | 0 | 0 | 1 |
| Tax | 13 | 18 | 11 | 8 | 10 |
| Web benefit | 47 | 60 | 36 | 30 | 28 |
The quarter results of the corporate presentations gross sales of Rs 198 crore for March 2025, whilst in December 2024 it was once Rs 159 crore. The online benefit for this quarter was once Rs 12 crore.
| Metric | March 2025 | December 2024 | September 2024 | June 2024 | March 2024 |
|---|---|---|---|---|---|
| Gross sales | 198 | 159 | 165 | 137 | 163 |
| Different source of revenue | 1 | 0 | 3 | 3 | 2 |
| Overall source of revenue | 199 | 160 | 169 | 141 | 166 |
| Overall expenditure | 182 | 146 | 150 | 129 | 146 |
| EBIT | 17 | 13 | 18 | 12 | 19 |
| Hobby | 0 | 0 | 0 | 0 | 0 |
| Tax | 4 | 2 | 3 | 2 | 4 |
| Web benefit | 12 | 10 | 15 | 9 | 15 |
As well as, the corporate’s money glide was once Rs 37 crore from working actions for the tip of March 2025, whilst the funding actions ended in money outflow of Rs 19 crore, and outflow of Rs 4 crore was once noticed in finance actions.
The stability sheet presentations that through March 2025, Anuh Pharma has a proportion capital of Rs 25 crore and Reserve and Surplus Rs 300 crore. The whole liabilities of the corporate are Rs 506 crore, whilst the overall belongings are Rs 506 crore.
The primary monetary ratio presentations elementary EPS of Rs 9.45 and e book price of Rs 65.06 in line with proportion for the yr ended on March 2025. Dividend was once Rs 1.50 in line with proportion. The corporate’s board has really helpful this bonus to praise shareholders.